Quickly bring frozen iRBCs to room temperature by thawing in your hands
Add 20uL MTS slowly and dropwise while flicking the cryovial, then rest for 5 minutes
Add 1mL MTS slowly and dropwise while flicking cryovial
Transfer iRBCs to 15mL conical tube and then centrifuge (1500rpm, 5 minutes)\
Aspirate supernatant and resuspend pelleted RBCs by flicking
Add 1mL 50:50 MTS slowly and dropwise while flicking tube, then centrifuge (1500rpm, 5 minutes)
Aspirate supernatant and resuspend pelleted RBCs by flicking
Add 1mL PBS slowly and dropwise while flicking tube, then centrifuge (1500rpm, 5 minutes)
Aspirate supernatant and resuspend pelleted RBCs by flicking
Raise 15mL conical tube volume to 5mL with R10
Remove 10uL resuspended cells, add to 10uL Trypan Blue, and count cells either manually (hemocytometer) or automatically (Countess Cell Counter)
-Opsonizing iRBCs:
Pre-label 15mL conical tubes according to opsonizing conditions
Split iRBCs into opsonizing conditions (adjust accordingly based on volume and number of cells):
Plasma (10%): 90uL RPMI + 10uL plasma
Antibody (1%): 99uL RPMI + 1uL antibody
Centrifuge (300g, 10 minutes)
Incubate (37°C, 5% CO2 ) for 1 hour, flicking tubes to mix every 15 minutes (4 times total)
After 1 hour, raise total 15mL conical volume to 500uL in RPMI and centrifuge (300g, 10 minutes)
Aspirate supernatant, resuspend in 500uL RPMI, and centrifuge (300g, 10 minutes)
Resuspend in appropriate volume needed for desired effector to target ratio (ex: 1:2, etc.)
-Co-incubation of PBMCs and opsonized RBCs:
Take plated PBMCs out of incubator and centrifuge (1500rpm, 5 minutes)
Aspirate supernatant and resuspend cells in 100uL R10
Optional: add degranulation antibody at this step
Add 100uL RBCs at concentration for desired effector to target ratio
Add ER inhibitors to all wells and then centrifuge plate (100g, 3 minutes)
Incubate for 5 hours (37°C, 5% CO2 )
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Lewis, S, Jagannathan, P and Lewis, S N(2023). Purification, freezing, and thawing of 3D7 P. falciparum-infected red blood cells and antibody-dependent cellular cytotoxicity (ADCC ) assay. Bio-protocol Preprint. bio-protocol.org/prep2175.
Ty, M., Sun, S., Callaway, P. C., Rek, J., Press, K. D., van der Ploeg, K., Nideffer, J., Hu, Z., Klemm, S., Greenleaf, W., Donato, M., Tukwasibwe, S., Arinaitwe, E., Nankya, F., Musinguzi, K., Andrew, D., de la Parte, L., Mori, D. M., Lewis, S. N., Takahashi, S., Rodriguez-Barraquer, I., Greenhouse, B., Blish, C., Utz, P., Khatri, P., Dorsey, G., Kamya, M., Boyle, M., Feeney, M., Ssewanyana, I. and Jagannathan, P.(2023). Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria. Science Translational Medicine 15(680). DOI: 10.1126/scitranslmed.add9012
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.